Scarica l'app Stockscreener
13.35
6.21%
0.78
Perspective Therapeutics Inc Borsa (CATX) Ultime notizie
Perspective Therapeutics to Present at the 37th Annual Congress of the European Association of Nuclear Medicine - The Manila Times
Marshall Wace LLP Sells 17,687,791 Shares of Perspective Therapeutics, Inc. (NYSE:CATX) - MarketBeat
Wall Street SWOT: CATX stock rides radiopharmaceutical wave amid clinical progress - Investing.com India
Wall Street SWOT: CATX stock rides radiopharmaceutical wave amid clinical progress - Investing.com
Deerfield Management Company L.P. Series C Decreases Stock Holdings in Perspective Therapeutics, Inc. (NYSE:CATX) - MarketBeat
Perspective Therapeutics Inc (CATX) can make a big difference with a little luck - SETE News
Perspective Therapeutics Inc [CATX] affiliate makes an insider purchase of 2,500 shares worth 39500.0. - Knox Daily
Truist Securities Initiates Coverage of Perspective Therapeutics (CATX) with Buy Recommendation - MSN
Perspective stock draws buy at Truist (NYSE:CATX) - Seeking Alpha
Perspective Therapeutics (NYSE:CATX) Shares Gap Up to $12.28 - MarketBeat
Perspective Therapeutics (NYSE:CATX) Research Coverage Started at Truist Financial - MarketBeat
Can you still get a good price for Perspective Therapeutics Inc (CATX) Shares at this point? - US Post News
Perspective Therapeutics stock undervalued despite pipeline in oncologyTruist - Investing.com
Affinity Asset Advisors LLC Reduces Position in Perspective Therapeutics, Inc. (NYSE:CATX) - MarketBeat
63,170 Shares in Perspective Therapeutics, Inc. (NYSE:CATX) Purchased by Rhumbline Advisers - Defense World
Vaxcyte Inc (PCVX) receives a Buy rating from Mizuho - Knox Daily
The time has not yet come to remove your chips from the table: Vaxcyte Inc (PCVX) - SETE News
Structure Therapeutics Inc ADR (GPCR)’s stock chart: A technical perspective - US Post News
Berkley W R Corp Grows Holdings in Perception Capital Corp. III (NASDAQ:PFTA) - MarketBeat
Ally Bridge Group NY LLC Purchases New Position in Perspective Therapeutics, Inc. (NYSE:CATX) - MarketBeat
Understanding the Risks of Investing in Perspective Therapeutics Inc (CATX) - Knox Daily
Perspective Therapeutics (NYSE:CATX) Trading Down 5.9% - MarketBeat
Ally Bridge Group NY LLC Makes New Investment in Perspective Therapeutics, Inc. (NYSE:CATX) - Defense World
Investing in Verve Therapeutics Inc (VERV) Is Getting More Attractive - Knox Daily
Upward Trajectory: Perspective Therapeutics Inc (CATX) Posts a Slidee, Closing at 13.23 - The Dwinnex
HighVista Strategies LLC Buys New Shares in Perspective Therapeutics, Inc. (NYSE:CATX) - Defense World
Investing in P3 Health Partners Inc (PIII): What You Must Know - Knox Daily
Structure Therapeutics’ (GPCR) “Overweight” Rating Reaffirmed at Cantor Fitzgerald - Defense World
PTC (NASDAQ:PTC) & WiMi Hologram Cloud (NASDAQ:WIMI) Head to Head Contrast - Defense World
Perspective Therapeutics, Inc.(NYSEAM:CATX) added to S&P Biotechnology Select Industry Index - Marketscreener.com
This under-the-radar value stock could soar 93%, say analysts - MSN
Bank of New York Mellon Corp Has $1.37 Million Position in Perspective Therapeutics, Inc. (NYSE:CATX) - MarketBeat
Bank of New York Mellon Corp Buys 93,548 Shares of Perspective Therapeutics, Inc. (NYSE:CATX) - Defense World
Taking a look at what insiders are doing to gauge the Perspective Therapeutics Inc (CATX)’s direction - Knox Daily
Vaxcyte Stock Soars to All-Time High of $119.64 Amidst Robust Growth - Investing.com
Vaxcyte, Inc. (NASDAQ:PCVX) Stake Lessened by E Fund Management Co. Ltd. - Defense World
Was Vaxcyte Inc (PCVX)’s session last reading good? - US Post News
Viking Therapeutics Inc [VKTX] Shares Rise 2.40 % on Wednesday - Knox Daily
WINTON GROUP Ltd Acquires New Position in Perspective Therapeutics, Inc. (NYSE:CATX) - MarketBeat
Priority Technology (NASDAQ:PRTH) Hits New 52-Week High at $6.90 - Defense World
A better buy-in window may exist right now for Perspective Therapeutics Inc (CATX) - SETE News
Perspective Therapeutics Inc (CATX) rating initates by BofA Securities - Knox Daily
Priority Technology (NASDAQ:PRTH) Shares Gap Up to $6.02 - MarketBeat
Vaxcyte Inc (PCVX) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News
Relmada Therapeutics Inc Inc. (RLMD) Price Performance: A Technical Analysis Perspective - The InvestChronicle
Liquidia Corp [LQDA] Investment Guide: What You Need to Know - Knox Daily
Perspective Therapeutics Inc (CATX)’s highs and lows: A closer look at its stock price fluctuations - US Post News
Perspective Therapeutics, Inc. (NYSE:CATX) Shares Sold by Sofinnova Investments Inc. - MarketBeat
Behind Perspective Therapeutics Inc’s 52-Week Range: Uncovering Opportunities for Investors - The InvestChronicle
Perspective Therapeutics Inc (CATX)’s Market Momentum: Closing Strong at 15.10, Down -4.67 - The Dwinnex
Analysts Set Perspective Therapeutics, Inc. (NYSE:CATX) PT at $19.80 - MarketBeat
Perspective Therapeutics, Inc. (NYSE:CATX) Receives Average Recommendation of “Buy” from Brokerages - Defense World
ITeos Therapeutics Inc Inc. (ITOS) Price Performance: A Technical Analysis Perspective - The InvestChronicle
Prepare Yourself for Liftoff: Perspective Therapeutics Inc (CATX) - SETE News
Perspective Therapeutics Inc (CATX) Becoming More Attractive for Investors - Knox Daily
Is Perspective Therapeutics Inc (CATX) a opportunity to investors? - US Post News
Analytical Lens: Exploring Perspective Therapeutics Inc (CATX)’s Financial Story Through Ratios - The Dwinnex
Perspective Therapeutics Presents at the World Molecular Imaging Congress 2024 - The Bakersfield Californian
Perspective Therapeutics Presents at the World Molecular Imaging Congress 2024 - StockTitan
Perspective Therapeutics’ (CATX) “Overweight” Rating Reaffirmed at Cantor Fitzgerald - Defense World
Perspective Therapeutics (NYSE:CATX) Stock Rating Reaffirmed by Cantor Fitzgerald - MarketBeat
Buying Buzz: Perspective Therapeutics Inc [CATX] Chief Financial Officer Hunt Jonathan Robert purchases 1,800 shares of the company – Knox Daily - Knox Daily
Check Out Perspective Therapeutics Inc (CATX)’s Trade Data Rather Than the Analysts’ Views - SETE News
Perspective gets FDA fast track status for radiopharmaceutical VMT01 - MSN
Perspective Therapeutics Granted Fast Track Designation for VMT01 for the Diagnosis and Treatment of MC1R-Positive Melanoma - ForexTV.com
Perspective gets FDA fast track status for radiopharmaceutical VMT01 (NYSE:CATX) - Seeking Alpha
Perspective Therapeutics Gets FDA Fast-Track Designation for VMT01 in Melanoma - MarketWatch
Keros Therapeutics Inc Inc. (KROS) Price Performance: A Technical Analysis Perspective - The InvestChronicle
Perspective Therapeutics Granted Fast Track Designation for VMT01 for the Diagnosis and Treatment of MC1R-Positive Melanoma - StockTitan
Perspective Therapeutics Inc (CATX) Stock: A 52-Week Tale of Drops and Gains - The InvestChronicle
Geron Corp. (GERN) receives a Neutral rating from Robert W. Baird - Knox Daily
Perspective Therapeutics (NYSE:CATX) Given Overweight Rating at Cantor Fitzgerald - Defense World
2024's 10 Best-Performing Stocks | Investing - U.S News & World Report Money
The Perspective Therapeutics Inc (CATX) had a good session last reading, didn’t it? - US Post News
0.25%
1.46%
Capitalizzazione:
|
Volume (24 ore):